Details of the Drug Inactive Ingredient (DIG)

General Information of DIG (ID: E06XKP)
DIG Name
Calcium phosphate
Synonyms    Click to Show/Hide the Synonyms of This DIG
Calcium phosphate; 7758-87-4; TRICALCIUM PHOSPHATE; Synthos; Calcium phosphate tribasic; Calcium orthophosphate; Tricalcium diphosphate; Calcigenol simple; beta-TCP; Phosphoric acid, calcium salt (2:3); Tricalcium orthophosphate; beta-Tricalcium phosphate; Calcium tertiary phosphate; Tertiary calcium phosphate; tri-calcium phosphate; FEMA No. 3081; Calciresorb;TCP; 10103-46-5; Phosphoric acid, calcium salt; UNII-K4C08XP666; tricalcium;diphosphate; tricalcium bis(phosphate); CHEBI:9679; K4C08XP666; Synthograft; Bonarka; Cerasorb; OSferion; beta-tri-Calcium phosphate; Natural whitlockite; Calcium Phosphate Nanoparticles; Calcium phosphate, 96%, pure; Caswell No. 148; Ceredex; Multifos; Ostram; Vitoss; TricOs; Calipharm T; Tricafos P; Calcium phosphate (3:2); Tricalcium bis(orthophosphate); CCRIS 3668; HSDB 879; JAX TCP; Calcium phosphate (Ca3(PO4)2); Calcium phosphate, for analysis, 35-40% (Ca); Calcium orthophosphate, tri-(tert); Tricalcium phosphate (Ca3(PO4)2); EINECS 231-840-8; EPA Pesticide Chemical Code 076401; Posture (calcium supplement); bone phosphate; Phosphoric acid calcium(2+) salt (2:3); Ca3(PO4)2; Bone ash; calcium-phosphate; alpha-TCP; Calcium phosphates; tricalciumphosphate; EINECS 233-283-6; Posture (TN); Hydroxyapatite Powder; MFCD00015984; Phosphoric acid, calcium salt (1:?); calcium phosphate basic; beta tricalcium phosphate; AI3-25607; alpha-Tricalcium phosphate; Ca3O8P2; alpha-tri-Calcium phosphate; EC 231-840-8; Calcium Phosphate Nanopowder; BONE POWDER, PURIFIED; INS NO.341(III); INS-341(III); CHEMBL2106566; DTXSID1049803; Calcium phosphate, AR, 96.0%; E-341(III); AKOS015833108; DB11348; Calcium phosphate, 98%,beta-phase basis; S338; Tricalcium bis(orthophosphate), with a fluorine content of less than 0,005 % by weight on the dry anhydrous product; Calcium phosphate, tribasic (ca.37% Ca); CS-0013475; FT-0645103; C08136; D00938; Q278387; UNII-97Z1WI3NDX component QORWJWZARLRLPR-UHFFFAOYSA-H; UNII-279O8I0433 component QORWJWZARLRLPR-UHFFFAOYSA-H; Calcium phosphate, Reagent for transient & stable DNA transfections; beta-tri-Calcium phosphate, >=95% beta-phase basis (unsintered powder); Calcium phosphate, purum p.a., >=96.0% (calc. as Ca3(PO4)2, KT); Tricalcium phosphate hydrate, nanopowder, <200 nm particle size (BET); alpha-tri-Calcium phosphate, puriss. p.a., >=75% alpha-phase basis (sinterted powder); alpha-tri-Calcium phosphate, Reagent for transient & stable DNA transfections; beta-tri-Calcium phosphate, puriss. p.a., >=95% beta-phase basis (sintered powder); beta-tri-Calcium phosphate, puriss. p.a., >=98% beta-phase basis (sintered Powder); beta-tri-Calcium phosphate, puriss. p.a., >=98% beta-phase basis (unsintered powder); 21063-37-6
DIG Function
Anticaking agent; Buffering agent; Desiccant; Diluent
PubChem CID
24456
Formula
Ca3O8P2
Canonical SMILES
[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[Ca+2].[Ca+2].[Ca+2]
InChI
1S/3Ca.2H3O4P/c;;;2*1-5(2,3)4/h;;;2*(H3,1,2,3,4)/q3*+2;;/p-6
InChIKey
QORWJWZARLRLPR-UHFFFAOYSA-H
   Click to Show/Hide the Molecular Data (Structure/Property) of This DIG
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=24456"></iframe>
3D MOL is not available 2D MOL
Physicochemical Properties Molecular Weight 310.2 Topological Polar Surface Area 173
XlogP N.A. Complexity 36.8
Heavy Atom Count 13 Rotatable Bond Count 0
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 8
Full List of Active Pharmaceutical Ingredients (APIs) Co-administrated with This DIG
       ICD Disease Classification 06 Mental/behavioural/neurodevelopmental disorder Click to Show/Hide
Paroxetine
 API Info
Major depressive disorder [ICD-11: 6A70]
 [1]
Imipramine
 API Info
Major depressive disorder [ICD-11: 6A70]
 [2]
       ICD Disease Classification 08 Nervous system disease Click to Show/Hide
Pyridostigmine
 API Info
Myasthenia gravis [ICD-11: 8C60]
 [3]
       ICD Disease Classification 11 Circulatory system disease Click to Show/Hide
Lisinopril
 API Info
Essential hypertension [ICD-11: BA00]
 [4]
Aspirin
 API Info
Myocardial infarction [ICD-11: BA41]
 [5]
Clonidine
 API Info
Essential hypertension [ICD-11: BA00]
 [6]
Amlodipine
 API Info
Angina pectoris [ICD-11: BA40]
 [7]
       ICD Disease Classification 15 Musculoskeletal/connective-tissue disease Click to Show/Hide
Diclofenac
 API Info
Knee osteoarthritis [ICD-11: FA01]
 [8]
References
1 FDA label for approved paroxetine from the official website of the U.S. Food and Drug Administration.
2 FDA label for approved imipramine from the official website of the U.S. Food and Drug Administration.
3 FDA label for approved pyridostigmine from the official website of the U.S. Food and Drug Administration.
4 FDA label for approved lisinopril from the official website of the U.S. Food and Drug Administration.
5 FDA label for approved aspirin from the official website of the U.S. Food and Drug Administration.
6 FDA label for approved clonidine from the official website of the U.S. Food and Drug Administration.
7 FDA label for approved amlodipine from the official website of the U.S. Food and Drug Administration.
8 FDA label for approved diclofenac from the official website of the U.S. Food and Drug Administration.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.